Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« On the Money | Main | Where Credit's Due »

September 29, 2002

A Rake's Progress

Email This Entry

Posted by Derek

Friday's Wall Street Journal has an extraordinary front-page story on the career of Sam Waksal, late of Imclone. If you haven't heard, it turns out that at every stage in his research career, these pesky. . .questions arose, bred by these nagging. . .doubts that what he was saying about his work was true.

The reporter, Geeta Anand, has obviously done a tremendous job on this one. You can't help but think that the folks at Bristol-Meyers Squibb found it pretty damn interesting. Here's the short history:

1974: post-doc at Stanford with Leonard Herzenberg. Asked to leave after a story about obtaining antibodies from another lab doesn't check out.
1975-1977: National Cancer Institute. Not offered a permanent position because of "disturbing patterns" in his research.
1977-1982: Tufts (Cancer Research Center.) Draws suspicion (results not backed up by actual research, trouble delivering actual data when backed to the wall on it.) Asked to leave.
1982-1985: Mt. Sinai. Asked to leave suddenly under circumstances which are still sealed. Rumors of falsified data.
1985: Founds Imclone.

Quite a trail. The article spends time trying to figure out how someone like this could go on from position to position without anyone ever putting a stop to him. A number of reasons are aired (potential legal action waiting if you trash someone in a recommendation, e.g.) - but there's another factor that I don't think is mentioned. That is, the desire to get someone the heck out of your lab.

And the best way to do that is provide them with a recommendation that'll get them employed somewhere else, where they can be somebody else's problem. I've seen this in action several times myself - grad students who went off to post-doc positions with everyone breathing a sigh of relief that they were finally out the door, post-docs hired in because everyone at their old lab was greasing the skids to shoot them out of the place.

And I've seen one or two people who were Waksal-ish, in a small-time way. I actually heard a "my NMR spectra were stolen" story - like someone needs a stack of NMRs. (You can tell that that one is from the days before digitized spectra, can't you?) And one post-doc I knew of spent some time on a large natural product project before floating off to another lab, leaving a pile of spectral data that the next guy had to sit down and figure out before he could get started. After going through the whole pile (two hours of stony silence, broken only by swishing paper,) this unlucky fellow looked up and said "This is not a very funny joke."

There has to be something more that we can do about such people. Any ideas?

Comments (0) + TrackBacks (0) | Category: The Dark Side


COMMENTS

EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings